Advances in lung cancer treatment using nanomedicines

A Sharma, D Shambhwani, S Pandey, J Singh… - ACS …, 2022 - ACS Publications
Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …

Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology

KE Sapsford, WR Algar, L Berti, KB Gemmill… - Chemical …, 2013 - ACS Publications
Bionanotechnology has now become firmly established in its own right as one of the
principle and focused subdisciplines within nanotechnology.(1-10) Bionanotechnology can …

A detailed insight of the tumor targeting using nanocarrier drug delivery system

S Batool, S Sohail, F ud Din, AH Alamri… - Drug Delivery, 2023 - Taylor & Francis
Human struggle against the deadly disease conditions is continued since ages. The
contribution of science and technology in fighting against these diseases cannot be ignored …

Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques

KE Sapsford, KM Tyner, BJ Dair… - Analytical …, 2011 - ACS Publications
REVIEW be defined as the intersection of nanotechnology and biology and is loosely
characterized by two somewhat converse foci:(i) exploiting nanomaterials (NMs) to …

[HTML][HTML] Current role of nanoparticles in the treatment of lung cancer

E Carrasco-Esteban… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Background: Worldwide, lung cancer is one of the leading causes of cancer death.
Nevertheless, new therapeutic agents have been developed to treat lung cancer that could …

Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos

M Karimi, H Mirshekari, SMM Basri, S Bahrami… - Advanced drug delivery …, 2016 - Elsevier
The main goal of drug delivery systems is to target therapeutic cargoes to desired cells and
to ensure their efficient uptake. Recently a number of studies have focused on designing bio …

Recent progress in the theranostics application of nanomedicine in lung cancer

A Mukherjee, M Paul, S Mukherjee - Cancers, 2019 - mdpi.com
Lung cancer is one of the leading causes of cancer-related death worldwide. Non-small cell
lung cancer (NSCLC) causes around 80% to 90% of deaths. The lack of an early diagnosis …

Phage therapeutics: from promises to practices and prospectives

K Bhargava, G Nath, A Bhargava, GK Aseri… - Applied Microbiology and …, 2021 - Springer
The rise in multi-drug resistant bacteria and the inability to develop novel antibacterial
agents limits our arsenal against infectious diseases. Antibiotic resistance is a global issue …

Bio-nanocarriers for lung cancer management: Befriending the barriers

S Rawal, M Patel - Nano-Micro Letters, 2021 - Springer
Lung cancer is a complex thoracic malignancy developing consequential to aberrations in a
myriad of molecular and biomolecular signaling pathways. It is one of the most lethal forms …

Emerging applications of nanoparticles for lung cancer diagnosis and therapy

UK Sukumar, B Bhushan, P Dubey, I Matai… - International Nano …, 2013 - Springer
Lung cancer is by far the leading cause of cancer-related mortality worldwide, most of them
being active tobacco smokers. Non small cell lung cancer accounts for around 85% to 90 …